Formaldehyde is an important precursor
to numerous industrial processes
and is produced in multimillion ton scale every year by catalytic
oxidation of methanol in an energetically unfavorable and atom-inefficient
industrial process. In this work, we present a highly selective one-step
synthesis of a formaldehyde derivative starting from carbon dioxide
and hydrogen gas utilizing a homogeneous ruthenium catalyst. Here,
formaldehyde is obtained as dimethoxymethane, its dimethyl acetal,
by selective reduction of carbon dioxide at moderate temperatures
(90 °C) and partial pressures (90 bar H2/20 bar CO2) in the presence of methanol. Besides the desired product,
only methyl formate is formed, which can be transformed to dimethoxymethane
in a consecutive catalytic step. By comprehensive screening of the
catalytic system, maximum turnover numbers of 786 for dimethoxymethane
and 1290 for methyl formate were achieved with remarkable selectivities
of over 90% for dimethoxymethane.
Due to the increasing
demand for formaldehyde as a building block
in the chemical industry as well as its emerging potential as feedstock
for biofuels in the form of dimethoxymethane and the oxymethylene
ethers produced therefrom, the catalytic transformation of carbon
dioxide to the formaldehyde oxidation state has become a focus of
interest. In this work, we present novel ruthenium complexes with
hetero-triphos ligands, which show high activity in the selective
transformation of carbon dioxide to dimethoxymethane. We substituted
the apical carbon atom in the backbone of the triphos ligand platform
with silicon or phosphorus and optimized the reaction conditions to
achieve turnover numbers as high as 685 for dimethoxymethane. The
catalytic systems could also be tuned to preferably yield methyl formate
with turnover numbers of up to 1370, which in turn can be converted
into dimethoxymethane under moderate conditions.
An efficient algorithmic workflow was developed to optimize seven process parameters of a homogeneous catalytic system with minimal experimental effort.
An improved immobilised Grubbs 2 nd generation catalyst and its application in flowthrough devices, shown for on-column reaction gas chromatography (ocRGC), has been studied. The coupling of a reaction capillary and a separation column in GC/MS allows direct reaction monitoring and analysis of conversion as well as reaction kinetics. The presented permanently bonded N-heterocyclic carbene ligand shows a great stability and activity in ring closing metathesis reactions. A salt-free approach was used to generate the carbene ligand, which can be directly monitored by mass spectrometry. The very flexible design of the immobilised ligand system in reaction channels and capillaries of flow through systems allows the preparation of various catalysts using a broad variety of metal precursors. This strategy of immobilised catalytically active complexes offers a wide range of on-column reactions combinable with fast reaction screening by high throughput experimentation.
On-column reaction gas chromatography (ocRGC) was successfully utilized as high-throughput platform for monitoring of the conversion and selectivity of hydrogenation of 5-methylfurfural catalyzed by polymer-stabilized Ru and Pd nanoparticles. We were able to elucidate the effect of various reaction conditions, mainly together with the catalyst loading on the conversion rate and the selectivity of the reaction. Our strategy yields significant improvements in reaction analysis times and cost effectiveness in comparison to standard methods. We are able to demonstrate that ocRGC approach provides valuable information about the reaction system that gives scientists a tool to design suitable catalytic systems for enhanced sustainable chemistry in the future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.